نتایج جستجو برای: rcc

تعداد نتایج: 4688  

Journal: :International journal of oncology 2007
Yoichi Mizutani Hiroyuki Nakanishi Yong Nan Li Hiroki Matsubara Kosuke Yamamoto Nodoka Sato Takumi Shiraishi Terukazu Nakamura Kazuya Mikami Koji Okihara Natsuki Takaha Osamu Ukimura Akihiro Kawauchi Norio Nonomura Benjamin Bonavida Tsuneharu Miki

X-linked inhibitor of apoptosis protein (XIAP) is the most potent caspase-inhibitory IAP family member and a negative regulator of various apoptotic stimuli. Thus, XIAP overexpression in cancer cells may select for tumor cell survival following various cytotoxic therapeutic modalities. The anatomical staging system in renal cell carcinoma (RCC) currently provides good prognostic information, al...

Journal: :Molecular cancer research : MCR 2013
Megan N Farley Laura S Schmidt Jessica L Mester Samuel Pena-Llopis Andrea Pavia-Jimenez Alana Christie Cathy D Vocke Christopher J Ricketts James Peterson Lindsay Middelton Lisa Kinch Nick Grishin Maria J Merino Adam R Metwalli Chao Xing Xian-Jin Xie Patricia L M Dahia Charis Eng W Marston Linehan James Brugarolas

UNLABELLED Renal cell carcinoma (RCC) clusters in some families. Familial RCC arises from mutations in several genes, including the von Hippel-Lindau (VHL) tumor suppressor, which is also mutated in sporadic RCC. However, a significant percentage of familial RCC remains unexplained. Recently, we discovered that the BRCA1-associated protein-1 (BAP1) gene is mutated in sporadic RCC. The BAP1 gene...

2017
Hao Rong Xue He Li Wang Yongjun He Longli Kang Tianbo Jin

Renal cell carcinoma (RCC) is considered to be a kind of cytokine reactive tumor. The research has been suggested that the host immune system can regulate the clinical course of RCC. Therefore, cytokine gene polymorphisms in RCC patients were analyzed was necessary. Our study is purpose to analyzing the interleukin-4(IL-4) polymorphisms associated with RCC risk from Han Chinese population. IL-4...

Journal: :Journal of Korean Medical Science 1999
H. J. Kim J. K. Park Y. G. Kim

T lymphocytes from patients with renal cell carcinoma (RCC) show reduced immune function and impaired activation of the transcription factor, NF-kappaB. We determined the mechanism of NF-kappaB suppression in T cells of RCC patient and determined whether supernatant fluid from RCC explants (RCC-S) induced the same phenotype of NF-kappaB suppression in normal T cells that is observed in patient ...

Journal: :BJU international 2000
H Kume S Takahashi S Teramoto K Isurugi

RCC accounts for < 3% of cancers in adults and < 85% of all primary malignant kidney tumours. The incidence of RCC has been steadily increasing for several years. In France, the incidence of RCC according to cancer registers was 12 per 100 000 men and 6 per 100 000 women in 1995, and mortality rates were over 7.5 per 100 000 men and 4.0 per 100 000 women, similar to reports from other European ...

2018
Nienie Qi Yue Chen Kan Gong Hailong Li

BACKGROUND To investigate the clinical manifestation, diagnosis, treatment, and outcome of simultaneous occurrence of renal cell carcinoma (RCC) and urothelial carcinoma. METHODS Twenty-seven consecutive patients with synchronous renal cell carcinoma and urothelial carcinoma treated in two tertiary medical centers from March 2005 to December 2015 were retrospectively reviewed. Their clinical,...

2017
Gregory Jackson Nora Fino Rhonda L Bitting

Introduction Renal cell carcinoma (RCC) is the most common malignancy to metastasize to the thyroid gland. The aims of this study are as follows: (1) to analyze the clinical characteristics of patients with thyroid involvement of RCC and (2) in patients with RCC thyroid metastasis, to determine whether RCC metastasis to glandular organs only portends a better prognosis compared with other patte...

2017
Dae Ro Lim Jung Kul Kuk Taehyung Kim Eung Jin Shin

PROPOSE There are embryological origins, anatomical, histological, genetic, and immunological differences between right-sided colon cancer (RCC) and left-sided colon cancer (LCC). Many studies have sought to determine the survival and prognosis according to tumor location. This study aimed to analyze outcomes between RCC and LCC. MATERIAL AND METHOD Between January 2000 and December 2012, dat...

Journal: :Oncology reports 2006
Toru Shimazui Takahiro Kojima Mizuki Onozawa Masahiko Suzuki Taeko Asano Hideyuki Akaza

Renal cell carcinomas (RCCs) primarily express cadherin-6 and N-cadherin rather than E-cadherin, and the aberrant expression of cadherin-6 correlates with a poor prognosis in patients with E-cadherin-absent RCC. However, the role of N-cadherin in RCC has not yet been elucidated. In this study, we analyze the expression pattern of N-cadherin in surgical RCC specimens and discuss the function of ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Jon Jones Hasan Otu Dimitrios Spentzos Shakirahmed Kolia Mehmet Inan Wolf D Beecken Christian Fellbaum Xuesong Gu Marie Joseph Allan J Pantuck Dietger Jonas Towia A Libermann

PURPOSE To address the progression, metastasis, and clinical heterogeneity of renal cell cancer (RCC). EXPERIMENTAL DESIGN Transcriptional profiling with oligonucleotide microarrays (22,283 genes) was done on 49 RCC tumors, 20 non-RCC renal tumors, and 23 normal kidney samples. Samples were clustered based on gene expression profiles and specific gene sets for each renal tumor type were ident...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید